Skip to content
Medical Health Aged Care

WEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I-IV Trial Delivery Capabilities

WEP Clinical 2 mins read
MORRISVILLE, N.C.--BUSINESS WIRE--

WEP Clinical (WEP), a full-service contract research organization (CRO), announces the acquisition of Siron Clinical (Siron), a Netherlands-based European CRO specializing in flexible, high-quality clinical operations for biotech companies. The acquisition expands WEP’s global footprint and strengthens its ability to deliver end-to-end Phase I–IV clinical trial solutions across complex, rare, and specialized therapeutic areas.

Founded in 2000, Siron is headquartered in the Netherlands, with additional offices in Belgium and Germany, and clinical research professionals based across Europe and the Middle East. The company specializes in clinical operations, including project management, clinical monitoring, quality assurance, and regulatory submissions. Siron has supported more than 120 studies and has a strong track record in orphan diseases, pediatric research, and medical device trials.

Jaswinder Khera, WEP Founder and CEO, said:

“This acquisition represents a significant milestone in the evolution of our CRO services. By combining WEP’s global infrastructure with Siron’s deep operational expertise in complex and niche indications, we can offer sponsors seamless support from early-phase development through post-approval research. Our shared culture, values, and commitment to execution excellence make this an ideal strategic fit, and we look forward to accelerating innovation and impact together.”

Jan Balemans, Siron Founder and CEO, said:

“Joining WEP gives our clients access to expanded services and global reach, while preserving the flexible, hands-on approach they value. We share WEP’s commitment to quality, transparency, and patient-focused delivery, and together we will provide a more robust and scalable solution for biotech sponsors worldwide.”

Siron will be integrated into WEP’s Clinical Trials division, enhancing WEP’s existing capabilities across trial design, regulatory strategy, start-up, patient recruitment, study execution, and close-out. Clients will benefit from a larger pool of experienced CRAs, project managers, and operational leaders, alongside WEP’s broader treatment access and commercialization offerings.

About WEP

WEP is a global CRO with expertise in designing, managing, and executing clinical trials across multiple therapeutic areas. With a strong focus on proactive project management, scientific integrity and regulatory compliance, WEP supports pharmaceutical and biotech companies in bringing life-changing therapies to market efficiently and safely.

About Siron

Siron is a European CRO providing flexible and scalable clinical operations expertise for biotech organizations. With more than two decades of experience executing complex clinical trials, Siron delivers localized insight, hands-on support, and adaptive solutions across the clinical development journey.


Contact details:

Contact Details:[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 23/02/2026
  • 13:28
Royal Australian College of GPs

Western Australian families shouldn’t bear the cost of keeping kids safe from meningococcal B: RACGP

The Royal Australian College of GPs (RACGP) is calling on the Western Australian Government to protect families by providing the life-saving meningococcal B vaccine for babies and teens. With 13 cases and one death in 2025, and four cases between December 2025 and January 2026 already, the RACGP is again urging the government to follow the lead of other states and act before more lives are put at risk. Meningococcal B is a rare but devastating disease, which can progress quickly and lead to death or permanent disability. Vaccination is recommended for every child aged two and under and every…

  • Contains:
  • Medical Health Aged Care
  • 23/02/2026
  • 10:03
The Australian Nursing and Midwifery Federation (ANMF)

ANMF appoints Catelyn Richards new Federal Assistant Secretary

The Australian Nursing and Midwifery Federation’s Federal Executive (ANMF), has appointed Catelyn Richards as its new Federal Assistant Secretary, marking a significant step in strengthening national leadership of the country’s largest union. Ms Richards is a Registered Nurse who commenced her career in paediatrics at the Royal Children’s Hospital in Melbourne. She has extensive experience in workforce advocacy and climate and health policy, having served as the ANMF’s first-ever Climate Change Officer since February, 2025. In that role, she worked to ensure that nursing and midwifery professionals had a voice in the development and implementation of national climate change policies.…

  • Medical Health Aged Care
  • 23/02/2026
  • 08:00
Monash University

New resource to support the improvement of medication management

Researchers at Monash University and Flinders University have released a new guide on how to establish and lead a quality improvement collaborative (QIC) to support senior healthcare professionals, managers and leaders across healthcare settings who are seeking to improve medication management practices. A QIC uses an evidenced based approach to bring healthcare professionals together from different sites to learn, share and implement best practice in a measurable and sustainable way. QICs have successfully been used in a range of different fields and settings to improve the quality of healthcare. Quality improvement strengthens health systems to deliver high quality person-centred care,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.